Connect with us

Published

on

Share on Pinterest New research suggests that an inexpensive and common prescription drug used to treat migraine, nerve and back pain, and depression may also help improve irritable bowel syndrome (IBS) symptoms. Dima Berlin/Getty ImagesAn inexpensive and widely available drug called amitriptyline has been shown to improve IBS symptomsThe drug was found to be almost twice as effective as a placebo in a recent trial. Amitriptyline may improve IBS symptoms by regulating the nervous system and stopping the reuptake of serotonin by the brain. Experts say this is promising news for people with IBS, but Amitriptyline is not without risk.

New research has found that amitriptyline, a cheap and widely available prescription drug, can improve symptoms of Irritable Bowel Syndrome (IBS).

The research presented Monday at UEG Week 2023 found that doses of the drug (commonly used to treat a range of health concerns, including migraine, nerve and back pain, and depression) could also improve IBS.

Conducted by researchers at the Universities of Leeds, Southampton, and Bristol the study shows that patients taking amitriptyline were almost twice as likely to report an overall improvement in symptoms as those taking a placebo.

During the study, doctors prescribed amitriptyline and patients managed their own dose based on the severity of their symptoms, using an adjustment document designed for the trial.

As a result of the study, the trial team are now recommending that doctors support their patients with IBS to use amitriptyline to manage their symptoms.

Amitriptyline is an effective treatment for IBS and is safe and well tolerated, co-chief Investigator Dr. Alexander Ford, Professor of Gastroenterology at the University of Leedss School of Medicine, said in a press release. This new rigorously conducted research indicates that general practitioners should support patients in primary care to try low-dose amitriptyline if their IBS symptoms havent improved with recommended first-line treatments.

The trial team has made an adjustment document available to clinicians and patients. How amitriptyline may help treat IBS symptoms

Jaspreet Randhawa, holistic pharmacist and founder of Whole Body Pharmacist, says the results of this study are promising for patients who are living with IBS.

She isnt surprised that amitriptyline is beneficial for gut issues, as well as many other ailments.

The results make sense when looking at the method of action of amitriptyline on the nervous system; it works by stopping the reuptake of serotonin by the brain, she explains. With 90-95% of serotonin production occurring in the gut, it would seem viable that the gut can be affected by a regular dose of amitriptyline.

Dr. Semiya Aziz, a general practitioner and founder of Say GP, agrees with this synopsis. She notes that many of the conditions amitriptyline is used to treat are associated with nerve-based issues.

We know that IBS is a condition which affects the gastrointestinal tract and currently a large amount of research is being carried out on the effects of gut-brain axis and nervous system, she points out.

Therefore, its not difficult to understand how amitriptyline can help with IBS symptoms when we have used this drug to treat people with nerve-related problems in the past.

In particular, amitriptyline may play an important role in regulating the vagus nerve.

Irritation of this nerve can cause vagal nerve dysfunction and possibly IBS symptoms, Aziz explains.

Effecting both the nervous system and serotonin, Aziz reasons that amitriptyline alleviates IBS symptoms by having an overall calming effect on gut function, relieving pain and causing changes in bowel activity. Amitriptyline may improve future treatment of IBS symptoms

So, what does all this mean for how IBS may be treated in the future?

Aziz believes the findings of the study may be an important milestone in helping to relieve individuals who have exhausted all other options of treatment for IBS, especially where IBS has impacted their work, social and daily lives.

In reality, this is a drug that could easily be prescribed in primary care for patients suffering from IBS because it is cheap and widely available but it has its limitations, she warns.

In particular, she says it may be difficult for patients to adjust or self-dose themselves safely.

Realistically if the medication is given out for IBS, it will need to be regularly monitored and dosages adjusted by the patients [doctor] or the healthcare support system, Aziz notes.

Still, Randhawa thinks that amitriptyline can be of great benefit to a proportion of people living with IBS.

I believe some people will find significant relief of their IBS symptoms and I am confident that [doctors] will be able to assess the patients ability to manage their symptoms and hope they will review frequently to support them on their healthcare journey, she surmises. Concerns and risks of using amitriptyline to treat IBS

Common IBS symptoms include cramping, bloating, excessive gas, and diarrhea or constipation which can be debilitating and can range from mild to severe.

In primary care, it is difficult to identify the severity of IBS, so it is difficult to know who would benefit from the treatment the most, Aziz points out.

Add to that, there is still much uncertainty about the causative factor for IBS.

Aziz says its often the result of many factors, such as muscle contractions of the intestine or irritation of the nervous system due to stress or infections.

Most patients who present in primary care with IBS will present with multifactorial medical issues which may not easily be resolved by using just amitriptyline alone, she explains.

Therefore, it can be difficult to know just how effective amitriptyline will be for you.

Another point to consider is that the drug may have serious side effects at higher doses. These can include headaches, dizziness, and suicidal thoughts. Takeaway

While there is rarely a one-size-fits-all treatment to improve any health condition, its certainly promising that a cheap and widely available drug has been shown to positively impact IBS symptoms in a trial.

IBS is a debilitating condition that affects many people and amitriptyline appears to be an effective and accessible way to treat it.

Continue Reading

Entertainment

Dances With Wolves and The Green Mile actor Graham Greene dies aged 73

Published

on

By

Dances With Wolves and The Green Mile actor Graham Greene dies aged 73

Graham Greene, the Canadian First Nations actor best known for his performance in Dancing With Wolves, has died aged 73.

The star died peacefully after a long illness.

His agent Michael Greene (not a relation) said he loved everything the actor “did for his people and for all the world” in a statement sent to Sky News.

“He was a great man of morals, ethics and character and will be eternally missed…God bless his beautiful soul.”

Greene was a “trailblazer” who opened doors for indigenous actors in Hollywood, US entertainment outlet Deadline reported.

He made his screen debut in an episode of the Canadian drama series The Great Detective in 1979, and his first film, Running Brave, followed in 1983.

But his breakthrough came when he was cast as Kicking Bird (Zintka Nagwaka) in Kevin Costner‘s Dances With Wolves, released in 1990.

Greene was nominated for best supporting actor, one of 12 nods for the film, which took home seven, including best picture.

He went on to appear in Maverick alongside Mel Gibson and Jodie Foster in 1994, Die Hard With A Vengeance with Bruce Willis and Samuel L Jackson in 1995, The Green Mile with Tom Hanks and Michael Clarke Duncan in 1999, The Twilight Saga: New Moon with Kristen Stewart and Robert Pattinson in 2009, and Wind River alongside Jeremy Renner and Elizabeth Olsen in 2017.

His TV credits included Wolf Lake, Defiance and Marvel’s Echo, as well as Tulsa King and The Last Of Us more recently.

Greene also had several projects in the works, according to movie database IMDB.

He is survived by his wife, Hilary Blackmore, his daughter Lilly Lazard-Greene and her son, Talo.

Continue Reading

Entertainment

Father Ted co-creator Graham Linehan ‘arrested at Heathrow over posts on X’

Published

on

By

Father Ted co-creator Graham Linehan 'arrested at Heathrow over posts on X'

Father Ted co-creator Graham Linehan has said he was arrested at Heathrow Airport, over social media posts sharing his views on trans rights.

Writing on Substack, the 57-year-old said that after flying into the UK from Arizona, he was detained by five armed officers and put in a cell before being questioned over posts published on X in April.

During questioning, he said a nurse checked on him and found his blood pressure had reached “stroke territory”, so he was taken to A&E.

A Met Police spokeswoman confirmed an arrest was made at Heathrow on Monday but did not identify Linehan.

In a statement, the force said: “On Monday 1 September at 1pm officers arrested a man at Heathrow Airport after he arrived on an inbound American Airlines flight.

“The man in his 50s was arrested on suspicion of inciting violence. This is in relation to posts on X.

“After being taken to police custody, officers became concerned for his health and he was taken to hospital. His condition is neither life-threatening nor life-changing.

“He has now been bailed pending further investigation.”

The arrest was made by officers from the force’s Aviation Unit, the Met spokeswoman said, adding that it is routine for officers policing airports to carry firearms.

“These were not drawn or used at any point during the arrest,” she said.

Continue Reading

Business

Pound drops as 30-year gilt yields at highest level this century

Published

on

By

Pound drops as 30-year gilt yields at highest level this century

The value of the pound has sunk – as the cost of 30-year government borrowing reached a high last seen in 1998.

The so-called spot rate saw one pound buy $1.336 on Tuesday, a low last seen in early August, and down from $1.353 earlier in the day.

Despite the dip, it’s still higher than the vast majority of the past year: in early September 2024, a pound bought $1.31.

Money blog: ‘She didn’t get me a wedding gift – even though I spent thousands on her’

The decline, however, means sterling is on course for the biggest one-day drop since April, when Donald Trump’s announcement of country-specific tariffs spooked markets.

The drop was similarly steep against the euro, with a pound momentarily buying €1.1486, a low not seen since November 2023, nearly two years ago. It’s also a fall from €1.1586 earlier in the trading session.

Before the so-called liberation day announcement, £1 equalled nearly €1.19.

It comes as the yield – the interest rate demanded by investors – on 30-year government bonds – loans taken by the state – hit 5.72%, the highest rate this century.

Why?

Yields are rising across the globe in the face of weak economic growth and the US trade war.

Investors are also concerned about UK government finances as Chancellor Rachel Reeves battles to stick to her fiscal rules to bring down debt and balance the budget.

High inflation and increased public debt from the pandemic have left a deficit between state spending and income.

There have been high-profile government U-turns on winter fuel payments and welfare spending cuts that have meant the chancellor has to look elsewhere to meet her self-imposed fiscal rules.

Read more:
Thames Water creditors offer £1bn ‘sweetener’
Empty flats that developers say sum up UK’s housing crisis

More expensive interest payments from rising bond yields have meant the country is stuck in a cycle of rising debt.

Today’s rises to the cost of government borrowing could not have come at a worse time for the public finances.

While a £14bn sale of new 10-year government debt – a record sum – was completed, it was achieved at the highest yield since 2008.

Lale Akoner, global market analyst at investment platform eToro, said of the auction: “For the government, this creates a paradox – market confidence in UK debt is robust, but financing that debt is increasingly expensive, constraining budget flexibility and raising the stakes for fiscal discipline ahead of the autumn budget.”

The yield on 10-year gilts, as they are known in the UK, later rose to its highest since January at 4.825%, up on the day but in line with their transatlantic equivalent, US Treasuries.

The global bond sell-off was also being reflected on stock markets.

The Dow Jones Industrial Average and tech-focused Nasdaq were both down by more than 1% at the open on Wall St.

In Europe, Germany’s DAX was 2% lower while the FTSE 100 was just 0.6% down as it is less exposed to declines in technology stocks which have accounted for much of the value growth seen over the summer.

The flight from risk also saw the spot price of gold, traditionally a safe haven for investors in times of uncertainty, briefly climb to a new record high of $3,578.40 per ounce.

Continue Reading

Trending